| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 8 buys and 53 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 569.5K | $30.19M | - | |
| CFO | 103.2K | $5.47M | - | |
| Other | 72.3K | $3.83M | - | |
| Other | 67.2K | $3.56M | - | |
| Other | 64.3K | $3.41M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Schuler Jack W45 | 10% Owner | Sell | 420,071 | $1.11 | $465,343.67 | -5.2% | +145.1% | +3965.9% | |
| Aug 26, 2022 | Schuler Jack W45 | 10% Owner | Sell | 180,523 | $2.70 | $487,961.96 | -1.7% | -43.7% | +162.5% | |
| Mar 31, 2022 | Hirano Patricia C | See Remarks | Buy | 20,000 | $0.00 | - | +16.8% | -11.8% | -36.0% | |
| Mar 31, 2022 | Mario Ernest | Director | Buy | 1,860,000 | $0.00 | - | +129.8% | -11.8% | -36.0% | |
| Mar 31, 2022 | Anish Bhatnagar | Chief Executive Officer | Buy | 60,000 | $0.00 | - | +16.2% | -11.8% | -36.0% | |
| Mar 31, 2022 | MacKaness James H | Chief Financial Officer | Buy | 40,000 | $0.00 | - | +146.5% | -11.8% | -36.0% | |
| Mar 31, 2022 | Schuler Jack W45 | 10% Owner | Buy | 4,000,000 | $0.00 | - | +102.3% | -11.8% | -36.0% | |
| Mar 29, 2022 | Sinclair Andrew | Director | Buy | 7,720,000 | $0.00 | - | +74.9% | -19.7% | -31.2% | |
| Mar 29, 2022 | Abingworth LLP | 10% Owner | Buy | 7,720,000 | $0.00 | - | +74.9% | -19.7% | -31.2% | |
| Feb 10, 2022 | Schuler Jack W45 | 10% Owner | Sell | 172,988 | $0.85 | $146,348.39 | -0.9% | -62.5% | -62.5% |